Correct Answer: C. Glucocerebrosidase
The clinical presentation of a 5-year-old with easy fatigability, irritability, and poor concentration, combined with bone marrow findings showing characteristic Gaucher cells (lipid-laden macrophages with a "wrinkled tissue paper" or "crumpled silk" appearance on light microscopy), is pathognomonic for Gaucher disease. This is the most common lysosomal storage disorder in India and worldwide. Gaucher disease results from deficiency of the enzyme glucocerebrosidase (also called β-glucosidase or acid β-glucosidase), which normally catalyzes the hydrolysis of glucocerebroside (glucosylceramide) into glucose and ceramide. Without this enzyme, glucocerebroside accumulates within macrophages of the reticuloendothelial system, creating the pathognomonic Gaucher cells. Type 1 Gaucher disease (non-neuronopathic, most common in India) presents with hepatosplenomegaly, bone involvement, anemia, and thrombocytopenia—consistent with the fatigue and irritability described. The enzyme deficiency is autosomal recessive, and diagnosis is confirmed by demonstrating reduced glucocerebrosidase activity in leukocytes or fibroblasts. Treatment in India includes enzyme replacement therapy (imiglucerase) and substrate reduction therapy (miglustat), though availability remains limited in resource-constrained settings.
Why the other options are wrong
A. Hexosaminidase — Hexosaminidase deficiency causes Tay-Sachs disease and Sandhoff disease, which present with neurodegeneration, cherry-red spot on the macula, developmental regression, and seizures—typically in infants, not a 5-year-old with fatigue and bone marrow Gaucher cells. These conditions accumulate GM2 gangliosides, not glucocerebroside, and do not produce Gaucher cells. B. Sphingomyelinase — Sphingomyelinase deficiency causes Niemann-Pick disease, characterized by accumulation of sphingomyelin and formation of foam cells (not Gaucher cells) in bone marrow and organs. Niemann-Pick presents with hepatosplenomegaly and neurological decline, but the bone marrow morphology and enzyme defect are distinct from Gaucher disease. D. N-acetyglucosaminidase — N-acetyglucosaminidase deficiency causes Sandhoff disease (when hexosaminidase B is affected) and mucolipidosis, which present with neurodegeneration, developmental delay, and cherry-red spots—not the clinical picture of a 5-year-old with fatigue and characteristic Gaucher cells on bone marrow aspiration.
High-Yield Facts
- Gaucher disease is caused by deficiency of glucocerebrosidase (β-glucosidase), the most common lysosomal storage disorder worldwide and in India.
- Gaucher cells are lipid-laden macrophages with a pathognomonic 'wrinkled tissue paper' or 'crumpled silk' appearance on light microscopy, diagnostic on bone marrow aspiration.
- Type 1 Gaucher disease (non-neuronopathic, ~90% of cases) presents with hepatosplenomegaly, anemia, thrombocytopenia, bone pain, and fatigue—no primary CNS involvement.
- Enzyme replacement therapy (imiglucerase) and substrate reduction therapy (miglustat) are standard treatments; diagnosis confirmed by reduced glucocerebrosidase activity in leukocytes.
- Autosomal recessive inheritance; higher prevalence in Ashkenazi Jewish populations, but increasingly recognized in Indian populations.
Mnemonics
Gaucher = Glucose + Ceramide Gaucher disease → Glucose + Ceramide (glucocerebrosidase breaks down glucocerebroside into glucose and ceramide). When enzyme is absent, glucocerebroside piles up in macrophages → Gaucher cells. Lysosomal Storage Diseases: Enzyme → Cell Type Gaucher (glucocerebrosidase) → Gaucher cells (wrinkled tissue paper); Niemann-Pick (sphingomyelinase) → Foam cells; Tay-Sachs (hexosaminidase) → Cherry-red spot + neurodegeneration. Use this to differentiate on bone marrow morphology.
NBE Trap
NBE may pair Niemann-Pick disease (sphingomyelinase deficiency) with bone marrow findings to trap students who confuse foam cells with Gaucher cells, or conflate hepatosplenomegaly in both conditions. The discriminator is the pathognomonic 'wrinkled tissue paper' morphology of Gaucher cells and the specific enzyme deficiency.
Clinical Pearl
In Indian pediatric practice, Gaucher disease should be suspected in any child presenting with unexplained hepatosplenomegaly, anemia, or thrombocytopenia; bone marrow aspiration showing Gaucher cells is the quickest diagnostic clue before enzyme assay confirmation. Early recognition allows timely referral for enzyme replacement therapy, which can halt disease progression and improve quality of life—critical in resource-limited settings where diagnosis is often delayed.
_Reference: Robbins Ch. 5 (Genetic Disorders); Harrison Ch. 356 (Lysosomal Storage Diseases); KD Tripathi Ch. 48 (Lipid Metabolism Disorders)_